|Source:||The roots of Aconitum kusnezoffii Reichb.|
|Biological Activity or Inhibitors:||1. Aconine can inhibit RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression.
2. Aconine has GW26-e4470 effect on the expression of Sirt-1 and eNOS system in EAhy926 cell injured by Homocysteine.
3. Aconine can attenuate hepatic fat degeneration of rats with fatty liver induced by high-fat diet through decreasing TG,TC deposit in liver.
|Solvent:||Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.|
|Storage:||Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: email@example.com
|After receiving:||The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.|
|1 mg||5 mg||10 mg||20 mg||25 mg|
|1 mM||2.0016 mL||10.008 mL||20.016 mL||40.032 mL||50.04 mL|
|5 mM||0.4003 mL||2.0016 mL||4.0032 mL||8.0064 mL||10.008 mL|
|10 mM||0.2002 mL||1.0008 mL||2.0016 mL||4.0032 mL||5.004 mL|
|50 mM||0.04 mL||0.2002 mL||0.4003 mL||0.8006 mL||1.0008 mL|
|100 mM||0.02 mL||0.1001 mL||0.2002 mL||0.4003 mL||0.5004 mL|
Nat Prod Commun. 2014 Jun;9(6):785-6.
|Ring A conformation of aconine and pseudaconine in CDCl3.[Pubmed: 25115078]|
|On the basis of intensive interpretation of the 1H NMR spectroscopic data, the ring A conformation of Aconine (1) was speculated as twist boat in CDCl3, and as chair or twist boat in acetone-d6 and pyridine-d5. The ring A of pseudAconine (2) adopts the chair conformation in CDCl3, acetone-d6, and pyridine-ds. Accordingly, the boat conformation of ring A in these two diterpenoid alkaloids in CDCl3 reported in the literature  should be revised. The difference in 13C NMR data for the same compound (1 or 2) in two different solvents (CDCl3, pyridine-d5) can be attributed to solvent effects.|
J Pharm Sci. 1977 Sep;66(9):1331-2.
|Selective estimation of aconitine in presence of aconine and benzoylaconine.[Pubmed: 903876]|
|A selective and simple colorimetric method is presented for the estimation of aconitine in drugs in the presence of Aconine and benzoylAconine. The method is based on the formation of an iron hydroxamate complex through the acetate ester group to which the biological activity is due. The color is measured at 530 nm (5--250 microgram/ml). Under the experimental conditions, neither the benzoyl group of benzoylAconine nor Aconine is involved in the process of hydroxylaminolysis.|
Zhongguo Zhong Yao Za Zhi. 2014 Dec;39(24):4798-803.
|[Effects of steaming and baking on content of alkaloids in Aconite Lateralis Radix (Fuzi)].[Pubmed: 25898581]|
|To study the effect of steaming and baking process on contents of alkaloids in Aconite Lateralis Radix (Fuzi), 13 alkaloids were analyzed by UPLC-MS/MS equipped with ESI ion source in MRM mode. In steaming process, the contents of diester-diterpenoid alkaloids decreased rapidly, the contents of monoester-diterpenoid alkaloids firstly increased, reached the peak at 40 min, and then deceased gradually. The contents of Aconine alkaloids (mesAconine, Aconine and hypAconine) increased all the time during processing, while the contents of fuziline, songorine, karacoline, salsolionl were stable or slightly decreased. In baking process, dynamic variations of alkaloids were different from that in the steaming process. Diester-diterpenoid alkaloids were degraded slightly slower than in steaming process. Monoester-diterpenoid alkaloids, Aconine alkaloids and the total alkaloids had been destroyed at different degrees, their contents were significantly lower than the ones in steaming Fuzi at the same processing time. This experiment revealed the dynamic variations of alkaloids in the course of steaming and baking. Two processing methods which can both effectively remove the toxic ingredients and retain the active ingredients are simple and controllable, and are valuable for popularization and application.|
Acta Pharmacol Sin. 2016 Feb; 37(2): 255–263.
|Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression.[Pubmed: 26592521]|
|Aconine (0.125, 0.25 μmol/L) did not affect the viability of RAW264.7 cells, but dose-dependently inhibited RANKL-induced osteoclast formation and bone resorptive activity. Furthermore, Aconine dose-dependently inhibited the RANKL-induced activation of NF-κB and NFATc1 in RAW264.7 cells, and subsequently reduced the expression of osteoclast-specific genes (c-Src, β3-Integrin, cathepsin K and MMP-9) and the expression of dendritic cell-specific transmembrane protein (DC-STAMP), which played an important role in cell-cell fusion. These findings suggest that Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing the activation of NF-κB and NFATc1 and the expression of the cell-cell fusion molecule DC-STAMP.|
J. Am. Coll. Cardiol., 2015, 66(16):C92-3.
|GW26-e4468 Effect of Aconine on the expression of Caveolin-1 and eNOS in EAhy926 cell injured by Homocysteine[Reference: WebLink]|
|To detect the effection of Sini Decoction on EAhy926 cell injured by homocysteine, well growing EAhy926 cells were cultured in culture plate. 24 h later, cells were cultured with DMEM medium containing 2% fetal calf serum for 8 h to make cells hungry, then cultured with medium containing Sini Decoction 0, 0.25, 0.5, 1.0 g/ml respectively for 30 min, then cultured with medium containing homocysteine 4.0 μmol/l for 24 h. It was found that, compared with control group, attached cells in Sini Decoction groups grew better, and attached cells in Sini Decoction 1.0 g/ml plus homocysteine 4.0 μmol/l group grew best. Detected by western-blot, it was found that, compared with control group, there was no obvious change of protein of Caveolin-1 and eNOS in Sini Decoction 1.0 g/ml group, but in homocysteine 4.0 μmol/l medol group, expression of Caveolin-1 protein enhanced obviously, expression of eNOS protein weakened obviously, and in Sini Decoction groups, expression of Caveolin-1 protein weakened, and expression of eNOS protein enhanced, and in Sini Decoction 1.0 g/ml plus homocysteine 4.0 μmol/l group it was the most obvious p<0.05). Detected by fluorescent quantitation, it was found that, compared with control group, there was no obvious change of mRNA of Caveolin-1 and eNOS in Sini Decoction 1.0 g/ml group, but in homocysteine 4.0 μmol/l medol group, expression of Caveolin-1 mRNA enhanced obviously, expression of eNOS mRNA weakened obviously, and in Sini Decoction groups, expression of Caveolin-1 mRNA weakened, and expression of eNOS mRNA enhanced, and in Sini Decoction 1.0 g/ml Plus homocysteine 4.0 μmol/l group, it was the most obvious p<0.05). Conclusions Homocysteine may injure EAhy926 cell by enhancing the expression of caveolin-1 then suppressing the expression of eNOS, while Sini Decoction may protect EAhy926 cell by suppressing the expression of caveolin-1 then enhancing the expression of eNOS.|